9 Einträge gefunden

1. Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

   1. Waizenegger, J S
   2. Ben-Batalla, I
   3. Weinhold, N
   4. Meissner, T
   5. Wroblewski, M
   6. Janning, M
   7. Riecken, K

   2020 - Forschungsinformationssystem des UKE
2. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

   1. Waizenegger, J S
   2. Ben-Batalla, I
   3. Weinhold, N
   4. Meissner, T
   5. Wroblewski, M
   6. Janning, M
   7. Riecken, K

   2015 - Forschungsinformationssystem des UKE
3. Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients

   1. Yousef, S
   2. Marvin, J
   3. Steinbach, M
   4. Langemo, A
   5. Kovacsovics, T
   6. Binder, M
   7. Kröger, N

   2015 - Forschungsinformationssystem des UKE
4. TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer

   1. Berdien, B
   2. Mock, U
   3. Atanackovic, D
   4. Fehse, B

   2014 - Forschungsinformationssystem des UKE
5. Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma

   1. Atanackovic, D
   2. Luetkens, T
   3. Kröger, N

   2014 - Forschungsinformationssystem des UKE
6. Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4+ and CD8+ T-cell responses in multiple myeloma patients

   1. Reinhard, H
   2. Yousef, S
   3. Luetkens, T
   4. Fehse, B
   5. Berdien, B
   6. Kröger, N
   7. Atanackovic, D

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
7. MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients

   1. Nuber, N
   2. Curioni-Fontecedro, A
   3. Dannenmann, S R
   4. Matter, C
   5. von Boehmer, L
   6. Atanackovic, D
   7. Knuth, A

   2013 - Forschungsinformationssystem des UKE
8. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).

   1. Kröger, Nicolaus
   2. Shimoni, A
   3. Zabelina, Tatjana
   4. Schieder, H
   5. Panse, Jens
   6. Ayuketang Ayuk, Francis
   7. Wolschke, Christine

   2006 - Forschungsinformationssystem des UKE
9. Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study.

   1. Hegewisch-Becker, S
   2. Gruber, Y
   3. Corovic, A
   4. Pichlmeier, U
   5. Atanackovic, D
   6. Nierhaus, Axel
   7. Hossfeld, D K

   2002 - Forschungsinformationssystem des UKE